<?xml version="1.0" encoding="UTF-8"?>
<p>Limited data exists on the prevalence and clinical features of MERS during pregnancy, birth, and the postnatal period. It is likely, however, that the immunological changes that normally occur in pregnancy may alter susceptibility to the MERS-CoV and the severity of clinical illness [
 <xref rid="B60-viruses-12-00194" ref-type="bibr">60</xref>]. Pregnant women infected with SARS-CoV, a related coronavirus, appear to have increased morbidity and mortality when compared to non-pregnant women, suggesting that MERS-CoV could also lead to severe clinical outcomes in pregnancy. To date, however, very few pregnancy-associated cases (
 <italic>n</italic> = 11) have been documented, with 91% having adverse clinical outcomes.
</p>
